Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/MD1 stock hub

FRA/MD1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/MD1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

381M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/MD1FRA/MD1

—

Loading chart…

In the news

Latest news · FRA/MD1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.9

P25 n/aP50 n/aP75 n/a

Trailing P/E27.4

P25 n/aP50 n/aP75 n/a

ROE32.1

P25 n/aP50 n/aP75 n/a

ROIC51.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/MD1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

NOK

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	DE
Employees	159
Employees Change	3%
Employees Change Percent	1.99
Enterprise value	EUR 364.8M
Exchange	Frankfurt Stock Exchange
Financial currency	NOK
First seen	2026-05-10
Industry	Electromedical and Electrotherapeutic Apparatus
Last refreshed	2026-05-10
Market cap	EUR 381M
Price	EUR 20.5
Price currency	EUR
Rev Per Employee	403,189.39x
Sic	3845
Symbol	fra/MD1
Website	https://www.medistim.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.65%
EV Earnings	26.25x
EV/EBIT	20.4x
EV/EBITDA	18.93x
EV/FCF	24.1x
EV/Sales	5.5x
FCF yield	3.97%
Forward P/E	25.88x
P/B ratio	8.44x
P/E ratio	27.41x
P/S ratio	5.94x
PE Ratio10 Y	38.86x
PE Ratio3 Y	33.15x
PE Ratio5 Y	42.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.96%
EBITDA Margin	27.83%
FCF margin	23.61%
Gross margin	80.71%
Gross Profit	EUR 51.7M
Gross Profit Growth	27.33%
Gross Profit Growth Q	24.34%
Gross Profit Growth3 Y	14.6%
Gross Profit Growth5 Y	15.37%
Net Income	EUR 13.9M
Net Income Growth	53.33%
Net Income Growth Q	78.81%
Net Income Growth3 Y	11.79%
Net Income Growth5 Y	18.07%
Pretax Margin	28.01%
Profit Margin	21.68%
Profit Per Employee	EUR 87,416
ROA	18.68
Roa5y	18.02
ROCE	35.15
ROE	32.08
Roe5y	30.66
ROIC	51.38
Roic5y	44.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	54.26%
Cagr3y	-2.78%
Cagr5y	-2.62%
Div CAGR3	23.88%
Div CAGR5	5.89%
EPS Growth	53.63
EPS Growth Q	79.83
EPS Growth3 Y	11.76
EPS Growth5 Y	18.04
FCF Growth	32.51%
FCF Growth Q	-5.66%
FCF Growth3 Y	20.32%
FCF Growth5 Y	22.18%
OCF Growth	30.73%
OCF Growth Q	-6.01%
OCF Growth10 Y	15.4%
OCF Growth3 Y	18.13%
OCF Growth5 Y	20.34%
Revenue Growth	24.38x
Revenue Growth Q	20.61x
Revenue Growth3 Y	12.9x
Revenue Growth5 Y	14.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.11
Assets	EUR 60.7M
Cash	EUR 18.7M
Current Assets	EUR 44M
Current Liabilities	EUR 13.2M
Debt	EUR 3.1M
Debt EBITDA	EUR 0.17
Debt Equity	EUR 0.07
Debt FCF	EUR 0.2
Equity	EUR 45.1M
Interest Coverage	43.04
Liabilities	EUR 15.6M
Long Term Assets	EUR 16.7M
Long Term Liabilities	EUR 2.4M
Net Cash	EUR 15.6M
Net Cash By Market Cap	EUR 4.1
Net Cash Growth	12.41%
Net Debt EBITDA	EUR -0.87
Net Debt Equity	EUR -0.35
Net Debt FCF	EUR -1.03
Tangible Book Value	EUR 36.1M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.8
Inventory Turnover	0.85
Net Working Capital	EUR 13.6M
Quick ratio	2.56
Working Capital	EUR 32.3M
Working Capital Turnover	EUR 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.21%
Dividend Growth	43.21%
Dividend Growth Years	1%
Dividend per share	EUR 0.73
Dividend Years	9
Dividend Yield	3.38%
Ex Div Date	2026-05-07
Last Dividend	EUR 0.73
Payout Frequency	Annual
Payout Ratio	70.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	54.21%
200-day SMA	20.1
3Y total return	-8.1%
50-day SMA	19.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-12.41%
All Time High	39.45
All Time High Change	-48.04%
All Time High Date	2021-10-15
All Time Low	6.67
All Time Low Change	207.35%
All Time Low Date	2019-02-11
ATR	0.56
Ch YTD	-5.96
High	20.8
High52	24.4
High52 Date	2025-10-29
High52ch	-15.98%
Low	20.5
Low52	14.15
Low52 Date	2025-05-08
Low52ch	45.39%
Ma50ch	4.61%
Price vs 200-day SMA	2.02%
RSI	51.25
RSI Monthly	54.2
RSI Weekly	53.38
Sharpe ratio	0.7x
Sortino ratio	1.25
Total Return	3.59%
Tr YTD	-2.51
Tr1m	13.96%
Tr1w	2.68%
Tr3m	15.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 17.3M
Operating Income Growth	49.68
Operating Income Growth Q	63.76
Operating Income Growth3 Y	11.58
Operating Income Growth5 Y	15.49
Operating margin	26.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,315,780%
Net Borrowing	-861,561.7
Shares Insiders	10.15%
Shares Institutions	77.58%
Shares Qo Q	0%
Shares Yo Y	-0.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 15.1M
Average Volume	27.1x
CAPEX	EUR -489,072
Ch1m	9.92
Ch1w	-0.97
Ch1y	43.36
Ch3m	11.72
Ch3y	-16.67
Ch5y	-22.93
Ch6m	0.99
Change	-5.53%
Change From Open	-1.44
Close	21.7
Days Gap	-4.15
Depreciation Amortization	663,136.4
Earnings Date	2026-04-14
EBIT	EUR 17.3M
EBITDA	EUR 17.8M
F Score	6
FCF	EUR 15.1M
FCF EV Yield	4.15x
Financing CF	-10,353,157
Fiscal Year End	December
Founded	1,984
Goodwill	1,300,859.7
Graham Number	6.39238
Graham Upside	-68.82
Income Tax	EUR 4.1M
Investing CF	-3,131,772
Is Primary Listing	0
Last Earnings Date	2026-04-14
Last Report Date	2025-12-31
Lynch Fair Value	EUR 13.51
Lynch Upside	-34.08
Ma150	20.11
Ma150ch	1.94%
Ma20	20.82
Ma20ch	-1.51%
Net CF	2,345,356
Next Earnings Date	2026-08-19
Open	20.8
P FCF Ratio	25.17
P OCF Ratio	24.38
Payment Date	2026-05-18
Position In Range	0
Ppne	7,309,601.3
Price Date	2026-05-08
Price EBITDA	EUR 21.35
Ptbv Ratio	10.56
Relative Volume	6.63x
Revenue	64,107,113x
Tax By Revenue	6.33x
Tax Rate	22.6%
Tr6m	4.7%

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/MD1 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$0.73 annual per share

Payout ratio

+70.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.9%

1 consecutive years of growth

Total shareholder yield

+3.6%

Next ex-dividend date: 2026-05-07

Performance

FRA/MD1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/MD1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.6%

Share of float held by funds and institutions

Insider ownership

+10.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

FRA/MD1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.2

Neutral momentum band

Price vs 200-day MA

+2.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/MD1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/MD1 stock rating?

fra/MD1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/MD1 analysis?

The full report lives at /stocks/fra/MD1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/MD1?

The latest report frames fra/MD1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/MD1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.